Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Glucose, Dates · 1 trial · 1 indication
Measuring the composition of dates, selection of patients and carrying out the study
| Arm | Type | Description |
|---|---|---|
| dates | ACTIVE_COMPARATOR | Each healthy and diabetic subjects received 50 grams equivalent of carbohydrates of the tested dates, On five separate days. |
| sugar | ACTIVE_COMPARATOR | Each healthy and diabetic subjects received 50 grams of glucose |
| Name | Type | Description |
|---|---|---|
| Glucose | OTHER | Each healthy and Diabetic volunteers received 50 grams of glucose |
| Dates | OTHER | Each healthy and diabetic volunteers received 50 grams equivalent of carbohydrates of each of the five selected dates, on five separate days. |
Inclusion Criteria: * Adult * Healthy or having controlled type 2 diabetes mellitus Exclusion Criteria: * Morbid obesity (BMI \> 40) * Presence of gastroenterological disorders * Alimentary tract surgery * A history of gastroenteritis in the prior six months * Any disease that may affect glucose ...
Glucose, Dates is being studied for use in Diabetes Mellitus. It is an investigational product in early clinical development, with a completed Phase 1 trial that tested the glycemic indices of five common varieties of dates among healthy and diabetic subjects.
Glucose, Dates is being developed by United Therapeutics Corporation, a company traded on the NASDAQ under the ticker UTHR. The product is currently in Phase 1 clinical development for Diabetes Mellitus.
Glucose, Dates is in Phase 1 clinical development. The single trial associated with it is an early Phase 1 study that has been completed. The product is investigational and has not been approved by regulatory authorities.
Glucose, Dates has one completed clinical trial, identified as NCT01307904. The study, titled "The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects," was an early Phase 1 trial conducted in the United Arab Emirates with 23 participants.
Glucose, Dates refers to a product being studied for its glycemic effects, specifically the glucose response to different varieties of dates. The clinical trial NCT01307904 tested the glycemic indices of five common date varieties in healthy and diabetic subjects, indicating the product is derived from dates.